Tuberculosis-associated immune reconstitution inflammatory syndrome in a non-immunocompromised patient
Open Access
- 1 October 2025
- journal article
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 21 (4) , 250255
Abstract
TB-IRIS is a rare complication of antitubercular therapy, particularly in immunocompetent patients. Timely recognition and initiation of corticosteroid therapy are crucial for effective management. https://bit.ly/4qH4RXBKeywords
This publication has 13 references indexed in Scilit:
- Tuberculosis IRIS: Pathogenesis, Presentation, and Management across the Spectrum of DiseaseLife, 2020
- TB-IRIS pathogenesis and new strategies for intervention: Insights from related inflammatory disordersTuberculosis, 2019
- Cavitary Lung DiseasesChest, 2018
- Tuberculosis-immune reconstitution inflammatory syndromeJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2016
- Thoracic manifestations of paradoxical immune reconstitution inflammatory syndrome during or after antituberculous therapy in HIV-negative patientsDiagnostic and Interventional Radiology, 2015
- Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patientsInfection, 2012
- Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndromeAIDS, 2010
- Cavitary Pulmonary DiseaseClinical Microbiology Reviews, 2008
- Risk Factors for Development of Paradoxical Response During Antituberculosis Therapy in HIV-Negative PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Side Effects of Corticosteroid TherapyJournal of Clinical Gastroenterology, 2001